Improving surgical response in women with endometriosis

Article

S

Researchers have found that women with red endometriosis develop more adnexal lesions following surgical therapy than women with black, white, or clear disease, and that Oxiplex/AP (FzioMed, Inc., San Luis Obispo, Calif.) gel reduces postsurgical adhesion formation, compared with surgery alone, in all subgroups.

The findings come from a small, controlled, double-blind trial involving 37 women (65 with adnexa) receiving laparoscopic surgical treatment for stage I–III endometriosis. The women were randomized to receive barrier gel treatment of the adnexa or surgery alone. They all underwent laparoscopic evaluation 6 to 10 weeks later.

The researchers found that women not using the gel who had at least 50% red lesions had a greater increase in ipsilateral adnexal adhesion scores than patients with mostly black, white, or clear lesions. In addition, women who received the gel had a greater decrease in adnexal adhesion score than control patients, regardless of lesion color.

Recent Videos
Baher Mankabady, MD, highlights safety of buprenorphine against OUD in pregnancy | Image Credit: linkedin.com.
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.